CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
88,360,453
Share change
+1,317,782
Total reported value
$1,385,502,991
Put/Call ratio
140%
Price per share
$15.68
Number of holders
166
Value change
+$33,691,495
Number of buys
85
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q4 2015

As of 31 Dec 2015, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 166 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 88,360,453 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, OppenheimerFunds, Inc., FIRST TRUST ADVISORS LP, VANGUARD GROUP INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, BlackRock Fund Advisors, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and FRONTIER CAPITAL MANAGEMENT CO LLC. This page lists 166 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.